Equillium (EQ) Capital Expenditures (2018 - 2026)
Equillium (EQ) reported Capital Expenditures of $3000.0 for Q1 2026, down 25.0% year-over-year from $4000.0 in Q1 2025, and down 93.18% quarter-over-quarter from $44000.0 in Q4 2025.
Equillium (EQ) Capital Expenditures (2018 - 2026) Analysis & Trends
Equillium (EQ) has 9 years of Capital Expenditures data on file, last reported at $3000.0 in Q1 2026.
- Capital Expenditures for Q1 2026 came in at $3000.0, down 25.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $47000.0 (up 56.67% YoY), and the FY2025 annual result was $48000.0, down 43.53% from the prior year.
- Capital Expenditures fell to $3000.0 in Q1 2026 per EQ's latest filing, from $44000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $276000.0 in Q4 2022 and troughed at -$274000.0 in Q3 2022.
- A 5-year average of $40909.1 and a median of $35000.0 in 2023 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2022 and 2025: Capital Expenditures tumbled 956.25% in 2022, then soared 1000.0% in 2025.
- A 5-year view of Capital Expenditures shows it stood at $276000.0 in 2022, then plunged by 87.32% to $35000.0 in 2023, then tumbled by 88.57% to $4000.0 in 2024, then soared by 1000.0% to $44000.0 in 2025, then plunged by 93.18% to $3000.0 in 2026.
- Business Quant data shows EQ's Capital Expenditures at $3000.0 in Q1 2026, $44000.0 in Q4 2025, and $4000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | 3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,000.00 |
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | 44,000.00 |
| Dec 31, 2025 | 44,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | 59,000.00 |
| Mar 31, 2024 | 59,000.00 |
| Dec 31, 2023 | 35,000.00 |
| Dec 31, 2023 | 35,000.00 |
| Dec 31, 2022 | 276,000.00 |
| Dec 31, 2022 | 276,000.00 |
| Sep 30, 2022 | -274,000.00 |
| Sep 30, 2022 | -274,000.00 |
| Jun 30, 2022 | 54,000.00 |
| Jun 30, 2022 | 54,000.00 |